Decreased electrical excitability of peripheral nerves in demyelinating polyneuropathies

Journal of Neurology Neurosurgery and Psychiatry

Volumn 62, Issue 4, 1997, Pages 398-400

  Meulstee, J ^a   Darbas, A ^a   Van Doorn, P A ^a   Van Briemen, L ^a   Van Der Meche F G A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Demyelinating polyneuropathy; Hypoexcitability; Peripheral nerves

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATING NEUROPATHY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; EXCITABILITY; GUILLAIN BARRE SYNDROME; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; MUSCLE ACTION POTENTIAL; NERVE BLOCK; PERIPHERAL NERVE; PRIORITY JOURNAL;

EID: 0030914271     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.62.4.398     Document Type: Article

References (10)

1. Kaku DA, Parry GJ, Malamut R, Lupski JR, Garcia CA. Uniform slowing of conduction velocities in Charcot-Marie-Tooth polyneuropathy type I. Neurology 1993;43: 2664-7.
2. Hoogendijk JE, de Visser M, Bour LJ, Ongerboer BW. Conduction block in hereditary motor and sensory neuropathy type I [letter]. Muscle Nerve 1992;15:520-1.
3. Brismar T. Changes in electrical threshold in human peripheral neuropathy. J Neurol Sci 1985;68:215-23.
4. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré Syndrome. Ann Neurol 1990;27(suppl):S21-4.
5. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy. Neurology 1991;41:617-8.
6. Gabreëls-Festen AAWM, Gabreëls FJM, Jennekens FGI. Hereditary motor and sensory neuropathies. Present status of types I, II and III. Clin Neurol Neurosurg 1993;95: 93-107.
7. Meulstee J, van der Meché FGA, and the Dutch Guillain-Barré Study Group. Electrodiagnostic criteria for polyneuropathy and demyelination: application in 135 patients with Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 1995;59:482-6.
8. Veltink PH, van Alste JA, Boom HBK. Influences of stimulation conditions on recruitment of myelinated fibres: a model study. IEEE Trans Biomed Eng 1988;35:917-24.
9. Van Doorn PA, Brand A, Strengers PFW, Meulstee J, Vermeulen M. High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double blind placebo-controlled cross over study. Neurology 1990;40:209-12.
10. Van der Meché FGA, Vermeulen M, Busch HFM. Chronic inflammatory demyelinating polyneuropathy: conduction failure before and during immunoglobulin or plasmatherapy. Brain 1989;112:1563-71.